Encouraging Signs For Arcus In TIGIT Race, But Gilead Holds Fire

Triplet Might Offer Arcus An Edge

 
• By Andrew McConaghie
Arcus Biosciences
Founded in 2015, Arcus is hoping anti-TIGIT candidate domvanalimab will be its big breakthrough. • Source: Alamy

More from Business

More from Scrip